Rusbase, an independent website devoted to technology, business and investment, published a list on Tuesday of the top five most interesting biotech startups in Russia, and all are residents of the Skolkovo Foundation. An ExoAtlet pilot demonstrates the...
Insilico Medicine , the parent company of Skolkovo resident biomed startup Insilico , has published a peer-review research paper calling for patients to regain control of their personal medical records, and even to profit from them. The Baltimore-based Insilico...
Insilico Medicine, the parent company of Skolkovo biomed startup Insilico, has launched a beta 1.0 version of a system that will study aging at the population level and track the efficacy of anti-aging interventions, and could one day help to prevent diseases...
Insilico Medicine, материнская компания сколковского стартапа «Инсилико», договорилась с сотрудничестве с фармгигантом GlaxoSmithKline. Соглашение предусматривает использование последних достижений в области искусственного интеллекта для создания...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
Американская биотехнологическая компания Selecta Biosciences (ее российское подразделение, «Селекта (РУС)», является резидентом биомедицинского кластера Фонда «Сколково») объявила о начале исследований 1 фазы нового неиммунонгенного...